{
    "2019-07-12": [
        [
            {
                "time": "",
                "original_text": "迈瑞医疗（300760）：Q2延续稳健增长趋势，全年大概率20%+增长【西南医药朱国广陈铁林团队】",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "Q2",
                        "稳健增长",
                        "20%+增长",
                        "西南医药",
                        "朱国广",
                        "陈铁林"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "迈瑞医疗：稀缺价值有望得到市场进一步重视",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "稀缺价值",
                        "市场重视"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}